ketadmin

Profile photo of ketadmin

About ketadmin

This author has not yet filled in any details.
So far has created 15 blog entries.

Ketamine provider in San Antonio, TX, interviewed on Daytime @ Nine

Dr. Carl Bonnett of San Antonio is the first ketamine infusion provider in Central Texas. On Jan 29, he appeared on Daytime @ Nine with Kimberly Crawford, which airs on Fox 29 in the San Antonio area. Click the link below to watch the interview, and hear Dr. Bonnett talk about ketamine infusion […]

By |January 30th, 2016|Uncategorized|Comments Off on Ketamine provider in San Antonio, TX, interviewed on Daytime @ Nine

Announcing our new website

We’re very pleased to announce the re-launch of the Ketamine Advocacy Network website.  The new site represents a complete redesign from the ground up.  We’ve invested hundreds of hours over 2.5 years gathering info from ketamine patients, clinicians, and researchers, and have custom-developed this site to present it in an effective way.  We think you’ll like […]

By |May 26th, 2015|Advocacy|4 Comments

A proposed study by a ketamine therapy provider

Dr. Steven Levine was one of the very first US doctors to offer ketamine infusion therapy for depression. A psychiatrist in Princeton, NJ, he has been providing the treatment since 2011. Based on his experience treating over 400 patients, Dr. Levine has designed a study to see if successful antidepressant outcomes can be […]

By |May 16th, 2015|Research|0 Comments

Thank you, Al Jazeera America

Al Jazeera America has just published a really outstanding piece on ketamine treatment for depression. Thank you to the author, Tim Bella, for telling the story in a way that balances the perspectives of doctors, researchers, and patients. Too many articles on ketamine try to manufacture controversy by hyping researchers’ concerns, which attracts […]

By |February 12th, 2015|Media Coverage|0 Comments

Thank you, National Public Radio

NPR affiliate KPCC in Southern California did a segment on ketamine for depression today, as part of their AirTalk program with Larry Mantle.  Dennis Hartman, founder and CEO of the Ketamine Advocacy Network, was a studio guest and described his own experience as a patient, and explained some of the basics about the treatment.  Also […]

By |December 15th, 2014|Media Coverage|2 Comments

Thank you, New York Times

Today’s New York Times article is driving a huge amount of traffic to our site.  If you are here to learn the basics about ketamine for depression (and bipolar and PTSD) see our FAQ page.  If you’re looking for a doctor who offers ketamine treatment, see our directory and interactive map.

We’ve been hard at work […]

By |December 10th, 2014|Media Coverage|1 Comment

Coming soon: website re-launch

We will be re-launching our website in December, with brand new content, tons of scientific research and media coverage, an updated directory of doctors, and links to ketamine studies where you can volunteer.  Plus a dramatically improved interface.  Stay tuned…

UPDATE 1/2/15:
Well, we didn’t get the re-launch done in December as we hoped.  That’s life when you’re operating […]

By |October 21st, 2014|Misc|0 Comments

You can influence depression research

Redkite has posted a link in the discussion forums to a survey being conducted by the James Lind Alliance. This influential group is seeking to shape the direction of depression research in the UK and elsewhere. You do not have to be a UK citizen to complete the survey. Time is short — the survey […]

By |July 30th, 2014|Research|0 Comments

Interactive map of ketamine doctors

We’ve added an interactive map to our directory of US ketamine therapy providers.

You may see an ad attached to the map. This is because we are using a free mapping service in order to keep our costs low. The ad is placed by the free mapping service, not us. We do not […]

By |July 8th, 2014|Advocacy|1 Comment

Please sign this petition regarding ketamine research

Please see this petition created by Depression Recovery Centers and consider signing.  It is self-explanatory, and compelling.

By |July 4th, 2014|Advocacy, Research|1 Comment
Skip to toolbar